Squarepoint Portfolio holdings
AUM
$45.5B
1-Year Return
6.73%
This Quarter Return
+2.86%
1 Year Return
+6.73%
3 Year Return
+22.51%
5 Year Return
+41.07%
10 Year Return
+76.91%
AUM
$30.6B
AUM Growth
+$3.77B
(+14%)
Cap. Flow
+$1.95B
Cap. Flow
% of AUM
6.39%
Top 10 Holdings %
Top 10 Hldgs %
27.95%
Holding
3,183
New
631
Increased
880
Reduced
964
Closed
576
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.11B |
| 2 |
Microsoft
MSFT
|
+$511M |
| 3 |
Real Estate Select Sector SPDR Fund
XLRE
|
+$221M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$202M |
| 5 |
Booking.com
BKNG
|
+$168M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$700M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$203M |
| 3 |
Oracle
ORCL
|
+$197M |
| 4 |
Gilead Sciences
GILD
|
+$154M |
| 5 |
VanEck Semiconductor ETF
SMH
|
+$137M |
Sector Composition
| 1 | Technology | 18.9% |
| 2 | Consumer Discretionary | 13.26% |
| 3 | Financials | 9.08% |
| 4 | Healthcare | 8.71% |
| 5 | Industrials | 8.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MBX
1826
MBX Biosciences, Inc. Common Stock
MBX
$334M
| $428K | ﹤0.01% |
+16,470
| New | +$428K |
|
1827
Kratos Defense & Security Solutions
KTOS
$11.4B
| $428K | ﹤0.01% |
18,359
-10,686
| -37% | -$249K |
|
1828
Huron Consulting
HURN
$2.46B
| $426K | ﹤0.01% |
+3,919
| New | +$426K |
|
1829
Immersion
IMMR
$221M
| $426K | ﹤0.01% |
+47,742
| New | +$426K |
|
1830
Aquestive Therapeutics
AQST
$599M
| $425K | ﹤0.01% |
85,392
+51,991
| +156% | +$259K |
|
1831
Skyworks Solutions
SWKS
$11.1B
| $425K | ﹤0.01% |
4,300
-48
| -1% | -$4.74K |
|
1832
Pathward Financial
CASH
$1.74B
| $424K | ﹤0.01% |
6,430
-9,840
| -60% | -$650K |
|
1833
Revvity
RVTY
$9.95B
| $424K | ﹤0.01% |
3,321
-23
| -0.7% | -$2.94K |
|
|
ARR
1834
Armour Residential REIT
ARR
$1.72B
| $424K | ﹤0.01% |
20,780
+9,370
| +82% | +$191K |
|
1835
Zentalis Pharmaceuticals
ZNTL
$113M
| $424K | ﹤0.01% |
115,105
-33,650
| -23% | -$124K |
|
1836
Copa Holdings
CPA
$4.82B
| $422K | ﹤0.01% |
+4,500
| New | +$422K |
|
1837
Primis Financial Corp
FRST
$270M
| $422K | ﹤0.01% |
+34,630
| New | +$422K |
|
1838
StoneX
SNEX
$5.14B
| $421K | ﹤0.01% |
7,707
-10,709
| -58% | -$585K |
|
1839
Zymeworks
ZYME
$1.24B
| $420K | ﹤0.01% |
33,438
-39,886
| -54% | -$501K |
|
1840
Alliant Energy
LNT
$16.6B
| $419K | ﹤0.01% |
6,905
-43
| -0.6% | -$2.61K |
|
1841
Titan Machinery
TITN
$466M
| $418K | ﹤0.01% |
30,019
-57,629
| -66% | -$803K |
|
1842
Axogen
AXGN
$773M
| $418K | ﹤0.01% |
29,815
-31,098
| -51% | -$436K |
|
1843
Celcuity
CELC
$2.44B
| $417K | ﹤0.01% |
+27,973
| New | +$417K |
|
1844
ClearPoint Neuro
CLPT
$315M
| $417K | ﹤0.01% |
37,201
-64,572
| -63% | -$724K |
|
1845
Regenxbio
RGNX
$479M
| $417K | ﹤0.01% |
39,705
-106,554
| -73% | -$1.12M |
|
1846
OneWater Marine
ONEW
$271M
| $416K | ﹤0.01% |
+17,407
| New | +$416K |
|
1847
Dianthus Therapeutics
DNTH
$1.22B
| $415K | ﹤0.01% |
+15,163
| New | +$415K |
|
1848
Treace Medical Concepts
TMCI
$470M
| $414K | ﹤0.01% |
71,360
-46,687
| -40% | -$271K |
|
1849
Voyager Therapeutics
VYGR
$243M
| $414K | ﹤0.01% |
+70,724
| New | +$414K |
|
|
SLRN
1850
DELISTED
ACELYRIN
SLRN
| $411K | ﹤0.01% |
83,345
+5,322
| +7% | +$26.2K |
|